{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:58:16Z","timestamp":1791320296901,"version":"4.3.1"},"reference-count":157,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lower respiratory tract infection (LRTI) is a major cause of neonatal morbidity and mortality worldwide. Maternal vaccination is an effective strategy in protecting young infants from LRTI, particularly in the first few months after birth when infant is most vulnerable, and most primary childhood vaccinations have not been administered. Additionally, maternal vaccination protects the mother from illness during pregnancy and the postnatal period, and the developing fetus from adverse outcomes such as stillbirth and prematurity. In this paper, we review the safety, efficacy, and effectiveness of maternal vaccines against LRTIs, such as pertussis, influenza, coronavirus disease 2019, and respiratory syncytial virus.<\/jats:p>","DOI":"10.1055\/a-2471-6906","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T23:56:01Z","timestamp":1734825361000},"page":"001-013","source":"Crossref","is-referenced-by-count":2,"title":["Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants"],"prefix":"10.1055","volume":"46","author":[{"given":"Nisha","family":"Makan-Murphy","sequence":"additional","affiliation":[{"name":"South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A","family":"Madhi","sequence":"additional","affiliation":[{"name":"South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"},{"name":"Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyaad","family":"Dangor","sequence":"additional","affiliation":[{"name":"South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"issue":"09","key":"ref1","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1473-3099(24)00176-2","article-title":"Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990\u20132021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"24","author":"R G Bender","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"T Vos","year":"2020","journal-title":"Lancet"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S2213-2600(16)00096-5","article-title":"Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study","volume":"4","author":"H J Zar","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"09","key":"ref4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"S Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(19)30721-4","article-title":"Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study","volume":"394","author":"K L O'Brien","year":"2019","journal-title":"Lancet"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1413456","article-title":"Viral bronchiolitis in children","volume":"374","author":"H C Meissner","year":"2016","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.7189\/jogh.12.10009","article-title":"Aetiology of childhood pneumonia in low- and middle-income countries in the era of vaccination: a systematic review","volume":"12","author":"C von Mollendorf","year":"2022","journal-title":"J Glob Health"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1542\/pir.35.12.519","article-title":"Respiratory syncytial virus infection and bronchiolitis","volume":"35","author":"G Piedimonte","year":"2014","journal-title":"Pediatr Rev"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/vaccines8040558","article-title":"Challenges for the newborn immune response to respiratory virus infection and vaccination","volume":"8","author":"K F Crofts","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"90","key":"ref10","doi-asserted-by":"crossref","first-page":"90ps27","DOI":"10.1126\/scitranslmed.3001880","article-title":"Development of newborn and infant vaccines","volume":"3","author":"G Sanchez-Schmitz","year":"2011","journal-title":"Sci Transl Med"},{"issue":"13","key":"ref13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra1509044","article-title":"Maternal immunization","volume":"376","author":"S B Omer","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3201\/eid1211.060152","article-title":"Emerging infections and pregnancy","volume":"12","author":"D J Jamieson","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"23","key":"ref15","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra1213566","article-title":"Pregnancy and infection","volume":"370","author":"A P Kourtis","year":"2014","journal-title":"N Engl J Med"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3201\/eid1207.051531","article-title":"Smallpox during pregnancy and maternal outcomes","volume":"12","author":"H Nishiura","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2105\/AJPH.30.10.1245","article-title":"Panum on measles: observations made during the epidemic of measles on the Faroe Islands in the year 1846 (a translation from the Danish)","volume":"30","author":"H Emerson","year":"1940","journal-title":"Am J Public Health Nations Health"},{"issue":"06","key":"ref18","first-page":"612","article-title":"1918 pandemic influenza and pneumonia in a large civil hospital","volume":"150","author":"J W Nuzum","year":"1976","journal-title":"Ill Med J"},{"issue":"14","key":"ref19","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jama.1919.02610140008002","article-title":"Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases","volume":"72","author":"J W Harris","year":"1919","journal-title":"J Am Med Assoc"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/0002-9378(59)90570-8","article-title":"Deaths from Asian influenza associated with pregnancy","volume":"78","author":"D W Freeman","year":"1959","journal-title":"Am J Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"m3320","DOI":"10.1136\/bmj.m3320","article-title":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis","volume":"370","author":"J Allotey","year":"2020","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(15)00838-7","article-title":"Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group","volume":"387","author":"L Alkema","year":"2016","journal-title":"Lancet"},{"issue":"06","key":"ref23","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1016\/S2214-109X(19)30163-9","article-title":"National, regional, and global levels and trends in neonatal mortality between 1990 and 2017, with scenario-based projections to 2030: a systematic analysis","volume":"7","author":"L Hug","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ajog.2021.10.041","article-title":"Maternal vaccination: a review of current evidence and recommendations","volume":"226","author":"M Etti","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/ijms17060894","article-title":"Dismantling the taboo against vaccines in pregnancy","volume":"17","author":"M de Martino","year":"2016","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/bmj.2.5255.785","article-title":"Neonatal tetanus in New Guinea. Effect of active immunization in pregnancy","volume":"2","author":"F D Schofield","year":"1961","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(10)60257-7","article-title":"Enrolling pregnant women in biomedical research","volume":"375","author":"R Macklin","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"ref28","first-page":"81","article-title":"Progress towards the global elimination of neonatal tetanus, 1989-1993","volume":"70","author":"Expanded Programme on Immunization (EPI)","year":"1995","journal-title":"Wkly Epidemiol Rec"},{"issue":"47","key":"ref29","first-page":"461","article-title":"Vaccines against influenza WHO position paper\u2014November 2012","volume":"87","year":"2012","journal-title":"Releve Epidemiol Hebd"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/AOG.0000000000000581","article-title":"Vaccinations for pregnant women","volume":"125","author":"G K Swamy","year":"2015","journal-title":"Obstet Gynecol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2021.08.009","article-title":"Vaccination in pregnancy - the when, what and how?","volume":"265","author":"N Dad","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bpobgyn.2021.03.008","article-title":"Vaccination in pregnancy: challenges and evidence-based solutions","volume":"76","author":"E Castillo","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/vaccines8010124","article-title":"Safety of administering live vaccines during pregnancy: a systematic review and meta-analysis of pregnancy outcomes","volume":"8","author":"A Laris-Gonz\u00e1lez","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.vaccine.2024.02.072","article-title":"Vaccine value profile for Klebsiella pneumoniae","volume":"42","author":"Z Dangor","year":"2024","journal-title":"Vaccine"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa2116045","article-title":"Potential for maternally administered vaccine for infant group B Streptococcus","volume":"389","author":"S A Madhi","year":"2023","journal-title":"N Engl J Med"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/pathogens13030200","article-title":"Prenatal maternal immunization for infant protection: a review of the vaccines recommended, infant immunity and future research directions","volume":"13","author":"E M Quincer","year":"2024","journal-title":"Pathogens"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"985646","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"P Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"D C Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0095-5108(18)30337-3","article-title":"In utero vaccination","volume":"21","author":"N Linder","year":"1994","journal-title":"Clin Perinatol"},{"issue":"02","key":"ref42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.earlhumdev.2010.11.003","article-title":"Transplacental transport of IgG antibodies to preterm infants: a review of the literature","volume":"87","author":"J P van den Berg","year":"2011","journal-title":"Early Hum Dev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","article-title":"Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy","volume":"8","author":"C R Wilcox","year":"2017","journal-title":"Front Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3389\/fmicb.2020.01499","article-title":"Maternal immunization: nature meets nurture","volume":"11","author":"A Saso","year":"2020","journal-title":"Front Microbiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"S Niewiesk","year":"2014","journal-title":"Front Immunol"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4049\/immunohorizons.1700057","article-title":"The impact of IgG transplacental transfer on early life immunity","volume":"2","author":"G G Fouda","year":"2018","journal-title":"Immunohorizons"},{"issue":"09","key":"ref47","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1473-3099(17)30390-0","article-title":"An update of the global burden of pertussis in children younger than 5 years: a modelling study","volume":"17","author":"K HT Yeung","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"07","key":"ref48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14760584.2020.1791092","article-title":"A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis","volume":"19","author":"W Kandeil","year":"2020","journal-title":"Expert Rev Vaccines"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"e5514","DOI":"10.5812\/ijp.5514","article-title":"Old disease and new challenges: major obstacles of current strategies in the prevention of pertussis","volume":"26","author":"I Sedighi","year":"2016","journal-title":"Iran J Pediatr"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12916-020-01699-3","article-title":"The burden of laboratory-confirmed pertussis in low- and middle-income countries since the inception of the Expanded Programme on Immunisation (EPI) in 1974: a systematic review and meta-analysis","volume":"18","author":"R Muloiwa","year":"2020","journal-title":"BMC Med"},{"issue":"06","key":"ref52","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/cid\/cit934","article-title":"The pertussis problem","volume":"58","author":"S A Plotkin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"09","key":"ref53","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1097\/INF.0000000000000795","article-title":"Pertussis across the globe: recent epidemiologic trends from 2000 to 2013","volume":"34","author":"T Tan","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1080\/21645515.2018.1480298","article-title":"Prevention of pertussis: an unresolved problem","volume":"14","author":"S Esposito","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"02","key":"ref55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/341027","article-title":"Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany","volume":"35","author":"P Juretzko","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"41","key":"ref56","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1016\/j.vaccine.2023.08.073","article-title":"Pertussis immunisation strategies to optimise infant pertussis control: a narrative systematic review","volume":"41","author":"E Tessier","year":"2023","journal-title":"Vaccine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"M D Decker","year":"1995","journal-title":"Pediatrics"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/vaccines8020217","article-title":"Acellular pertussis vaccine components: today and tomorrow","volume":"8","author":"K K Dewan","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"ref59","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/infdis\/jiv324","article-title":"The decline of pertussis-specific antibodies after tetanus, diphtheria, and acellular pertussis immunization in late pregnancy","volume":"212","author":"B Abu Raya","year":"2015","journal-title":"J Infect Dis"},{"issue":"02","key":"ref60","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1086\/421033","article-title":"Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum","volume":"190","author":"C M Healy","year":"2004","journal-title":"J Infect Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"G Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"g4219","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"K Donegan","year":"2014","journal-title":"BMJ"},{"issue":"18","key":"ref63","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2014.14825","article-title":"Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes","volume":"312","author":"E O Kharbanda","year":"2014","journal-title":"JAMA"},{"issue":"07","key":"ref64","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.vaccine.2015.12.046","article-title":"Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013","volume":"34","author":"E O Kharbanda","year":"2016","journal-title":"Vaccine"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review","volume":"20","author":"S Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"20","key":"ref66","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"16","author":"J D Cherry","year":"1998","journal-title":"Vaccine"},{"issue":"20","key":"ref67","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"J Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/S0264-410X(03)00407-9","article-title":"Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis","volume":"21","author":"J Storsaeter","year":"2003","journal-title":"Vaccine"},{"issue":"03","key":"ref69","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/315318","article-title":"Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis","volume":"181","author":"J Taranger","year":"2000","journal-title":"J Infect Dis"},{"issue":"03","key":"ref70","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/infdis\/161.3.487","article-title":"Natural history of pertussis antibody in the infant and effect on vaccine response","volume":"161","author":"J Van Savage","year":"1990","journal-title":"J Infect Dis"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"e1087","DOI":"10.1093\/cid\/ciac432","article-title":"Maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination during pregnancy: impact on infant anti-pertussis antibody concentrations by maternal pertussis priming series","volume":"76","author":"F P Havers","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"09","key":"ref72","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jama.1943.02840090026008","article-title":"The placental transmission of protective antibodies against whooping cough: by inoculation of the pregnant mother","volume":"121","author":"P Cohen","year":"1943","journal-title":"J Am Med Assoc"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpobgyn.2020.09.005","article-title":"The historical aspects of vaccination in pregnancy","volume":"76","author":"D W Mackin","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"12","key":"ref74","doi-asserted-by":"crossref","first-page":"a029454","DOI":"10.1101\/cshperspect.a029454","article-title":"What is wrong with pertussis vaccine immunity? The problem of waning effectiveness of pertussis vaccines","volume":"9","author":"N Burdin","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"16","key":"ref75","doi-asserted-by":"crossref","first-page":"E399","DOI":"10.1503\/cmaj.160193","article-title":"Effectiveness of pertussis vaccination and duration of immunity","volume":"188","author":"K L Schwartz","year":"2016","journal-title":"CMAJ"},{"issue":"47","key":"ref76","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1016\/j.vaccine.2015.07.085","article-title":"Maternal antibodies and infant immune responses to vaccines","volume":"33","author":"K M Edwards","year":"2015","journal-title":"Vaccine"},{"issue":"24","key":"ref77","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1016\/S0264-410X(03)00342-6","article-title":"Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants","volume":"21","author":"C A Siegrist","year":"2003","journal-title":"Vaccine"},{"issue":"07","key":"ref78","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jamapediatrics.2017.0638","article-title":"The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses : an individual participant meta-analysis","volume":"171","author":"M Voysey","year":"2017","journal-title":"JAMA Pediatr"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"689394","DOI":"10.3389\/fimmu.2021.689394","article-title":"The effect of tetanus-diphtheria-acellular-pertussis immunization during pregnancy on infant antibody responses: individual-participant data meta-analysis","volume":"12","author":"B Abu-Raya","year":"2021","journal-title":"Front Immunol"},{"issue":"01","key":"ref80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12884-017-1333-5","article-title":"Incidence of influenza virus infection among pregnant women: a systematic review","volume":"17","author":"M A Katz","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"01","key":"ref81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 Influenza: the mother of all pandemics","volume":"12","author":"J K Taubenberger","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1186\/s12879-019-4318-3","article-title":"Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis","volume":"19","author":"D Mertz","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"07","key":"ref83","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cid\/civ448","article-title":"Mortality associated with seasonal and pandemic influenza among pregnant and nonpregnant women of childbearing age in a high-HIV-prevalence setting-South Africa, 1999-2009","volume":"61","author":"S Tempia","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijid.2021.02.095","article-title":"The effect of influenza virus infection on pregnancy outcomes: a systematic review and meta-analysis of cohort studies","volume":"105","author":"R Wang","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"01","key":"ref85","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/1471-0528.14143","article-title":"Maternal influenza and birth outcomes: systematic review of comparative studies","volume":"124","author":"D B Fell","year":"2017","journal-title":"BJOG"},{"issue":"09","key":"ref86","doi-asserted-by":"crossref","first-page":"e016526","DOI":"10.1136\/bmjopen-2017-016526","article-title":"Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review","volume":"7","author":"D B Fell","year":"2017","journal-title":"BMJ Open"},{"issue":"01","key":"ref88","doi-asserted-by":"crossref","first-page":"e2243","DOI":"10.1002\/rmv.2243","article-title":"Influenza vaccines: past, present, and future","volume":"32","author":"Y H Kim","year":"2022","journal-title":"Rev Med Virol"},{"issue":"10","key":"ref89","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2307\/4590965","article-title":"Influenza immunization: statement","volume":"75","author":"L E Burney","year":"1960","journal-title":"Public Health Rep"},{"key":"ref90","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"issue":"03","key":"ref91","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/21645515.2018.1540807","article-title":"The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review","volume":"15","author":"M L Giles","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"02","key":"ref92","doi-asserted-by":"crossref","first-page":"e20200375","DOI":"10.1542\/peds.2020-0375","article-title":"Early childhood health outcomes following in utero exposure to influenza vaccines: a systematic review","volume":"146","author":"D YP Foo","year":"2020","journal-title":"Pediatrics"},{"issue":"04","key":"ref93","doi-asserted-by":"crossref","first-page":"e1003963","DOI":"10.1371\/journal.pmed.1003963","article-title":"Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: a longitudinal, population-based linked cohort study","volume":"19","author":"D Foo","year":"2022","journal-title":"PLoS Med"},{"issue":"08","key":"ref94","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/archdischild-2022-324269","article-title":"Association between maternal influenza vaccination and neurodevelopmental disorders in childhood: a longitudinal, population-based linked cohort study","volume":"108","author":"D Foo","year":"2023","journal-title":"Arch Dis Child"},{"issue":"15","key":"ref95","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants","volume":"359","author":"K Zaman","year":"2008","journal-title":"N Engl J Med"},{"issue":"09","key":"ref96","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1473-3099(17)30252-9","article-title":"Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial","volume":"17","author":"M C Steinhoff","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"04","key":"ref97","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"D Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"issue":"41","key":"ref98","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1016\/j.vaccine.2020.07.020","article-title":"Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South Africa","volume":"38","author":"A B Amin","year":"2020","journal-title":"Vaccine"},{"issue":"10","key":"ref99","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa1401480","article-title":"Influenza vaccination of pregnant women and protection of their infants","volume":"371","author":"S A Madhi","year":"2014","journal-title":"N Engl J Med"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"102448","DOI":"10.1016\/j.eclinm.2024.102448","article-title":"The safety and immunogenicity of vaccines administered to pregnant women living with HIV: a systematic review and meta-analysis","volume":"69","author":"E Nakabembe","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"09","key":"ref101","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1473-3099(16)30054-8","article-title":"Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial","volume":"16","author":"M D Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"32","key":"ref102","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.vaccine.2016.05.032","article-title":"Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: a retrospective cohort study","volume":"34","author":"A K Regan","year":"2016","journal-title":"Vaccine"},{"issue":"09","key":"ref103","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/cid\/ciy737","article-title":"Influenza vaccine effectiveness in preventing influenza-associated hospitalizations during pregnancy: a multi-country retrospective test negative design study, 2010-2016","volume":"68","author":"M G Thompson","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref104","doi-asserted-by":"crossref","first-page":"e012376","DOI":"10.1136\/bmjgh-2023-012376","article-title":"Are maternal vaccines effective and safe for mothers and infants? A systematic review and meta-analysis of randomised controlled trials","volume":"8","author":"O de Bruin","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"12","key":"ref105","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/infdis\/jiv339","article-title":"Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants","volume":"212","author":"M C Nunes","year":"2015","journal-title":"J Infect Dis"},{"issue":"06","key":"ref106","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-2600(19)30479-5","article-title":"Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials","volume":"8","author":"S B Omer","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"05","key":"ref107","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/INF.0000000000001914","article-title":"Maternal influenza immunization and prevention of severe clinical pneumonia in young infants: analysis of randomized controlled trials conducted in Nepal, Mali and South Africa","volume":"37","author":"S B Omer","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Y Li","year":"2022","journal-title":"Lancet"},{"issue":"50","key":"ref109","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1016\/j.vaccine.2016.10.090","article-title":"Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016","volume":"37","author":"B K Giersing","year":"2019","journal-title":"Vaccine"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v50i12a01","article-title":"Burden of disease of respiratory syncytial virus in infants, young children and pregnant women and people","volume":"50","author":"E M Abrams","year":"2024","journal-title":"Can Commun Dis Rep"},{"issue":"S 01","key":"ref111","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/infdis\/jiad449","article-title":"Burden of respiratory syncytial virus-associated acute respiratory infections during pregnancy","volume":"229","author":"S Kenmoe","year":"2024","journal-title":"J Infect Dis"},{"issue":"05","key":"ref112","first-page":"CD015134","article-title":"Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes","volume":"5","author":"E W Phijffer","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"ref113","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/infdis\/jiz390","article-title":"Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants","volume":"220","author":"F M Mu\u0148oz","year":"2019","journal-title":"J Infect Dis"},{"issue":"11","key":"ref114","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa2305478","article-title":"RSV prefusion F protein-based maternal vaccine - preterm birth and other outcomes","volume":"390","author":"I Dieussaert","year":"2024","journal-title":"N Engl J Med"},{"issue":"16","key":"ref115","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"B Kampmann","year":"2023","journal-title":"N Engl J Med"},{"issue":"41","key":"ref116","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","article-title":"Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: recommendations of the Advisory Committee on Immunization Practices - United States, 2023","volume":"72","author":"K E Fleming-Dutra","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"03","key":"ref117","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000536031","article-title":"Respiratory syncytial virus maternal vaccination in infants below 6 months of age: meta-analysis of safety, immunogenicity, and efficacy","volume":"121","author":"M P Mapindra","year":"2024","journal-title":"Neonatology"},{"issue":"05","key":"ref118","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMoa1908380","article-title":"Respiratory syncytial virus vaccination during pregnancy and effects in infants","volume":"383","author":"S A Madhi","year":"2020","journal-title":"N Engl J Med"},{"issue":"02","key":"ref119","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1093\/infdis\/jiad560","article-title":"Safety and immunogenicity of respiratory syncytial virus prefusion maternal vaccine coadministered with diphtheria-tetanus-pertussis vaccine: a phase 2 study","volume":"230","author":"N Hermida","year":"2024","journal-title":"J Infect Dis"},{"issue":"12","key":"ref120","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/infdis\/jiab505","article-title":"Safety and immunogenicity of a respiratory syncytial virus prefusion f vaccine when coadministered with a tetanus, diphtheria, and acellular pertussis vaccine","volume":"225","author":"J T Peterson","year":"2022","journal-title":"J Infect Dis"},{"issue":"12","key":"ref121","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/infdis\/jiab611","article-title":"Phase 1\/2 randomized study of the immunogenicity, safety, and tolerability of a respiratory syncytial virus prefusion F vaccine in adults with concomitant inactivated influenza vaccine","volume":"225","author":"A R Falsey","year":"2022","journal-title":"J Infect Dis"},{"issue":"03","key":"ref122","doi-asserted-by":"crossref","first-page":"100319","DOI":"10.1016\/j.ajogmf.2021.100319","article-title":"Pregnancy as a risk factor for severe coronavirus disease 2019 using standardized clinical criteria","volume":"3","author":"M C Oakes","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"12","key":"ref123","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S2213-2600(22)00360-5","article-title":"Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study","volume":"10","author":"S J Stock","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"22","key":"ref124","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.3390\/jcm10225458","article-title":"Pregnancy as a risk factor of severe COVID-19","volume":"10","author":"A Celewicz","year":"2021","journal-title":"J Clin Med"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ejogrb.2020.06.058","article-title":"Is pregnancy a risk factor of COVID-19?","volume":"252","author":"W N Phoswa","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"01","key":"ref126","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajog.2021.07.009","article-title":"SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis","volume":"226","author":"A Conde-Agudelo","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"05","key":"ref127","doi-asserted-by":"crossref","first-page":"522.e1","DOI":"10.1016\/j.ajog.2021.05.016","article-title":"Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study","volume":"225","author":"I Gurol-Urganci","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"01","key":"ref128","doi-asserted-by":"crossref","first-page":"e2253590","DOI":"10.1001\/jamanetworkopen.2022.53590","article-title":"Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US","volume":"6","author":"S Flaxman","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"25","key":"ref129","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1016\/j.vaccine.2023.03.038","article-title":"Safety of COVID-19 vaccines during pregnancy: a systematic review and meta-analysis","volume":"41","author":"A Ciapponi","year":"2023","journal-title":"Vaccine"},{"issue":"05","key":"ref130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"L R Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"27","key":"ref131","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"F P Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"06","key":"ref133","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico","volume":"386","author":"L M Dunkle","year":"2022","journal-title":"N Engl J Med"},{"issue":"19","key":"ref134","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJMoa2113017","article-title":"Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase","volume":"385","author":"H M El Sahly","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"ref135","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19","volume":"384","author":"J Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"ref136","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA COVID-19 vaccine safety in pregnant persons","volume":"384","author":"T T Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"issue":"01","key":"ref137","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/s41467-022-30052-w","article-title":"Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy","volume":"13","author":"S Prasad","year":"2022","journal-title":"Nat Commun"},{"issue":"24","key":"ref138","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.vaccine.2022.04.031","article-title":"Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021","volume":"40","author":"P L Moro","year":"2022","journal-title":"Vaccine"},{"key":"ref140","first-page":"rs.3.rs-798175","article-title":"Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020-21","author":"L Head Zauche","year":"2021","journal-title":"Res Sq"},{"issue":"03","key":"ref141","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/AOG.0000000000004693","article-title":"Association of gestational age at coronavirus disease 2019 (COVID-19) vaccination, history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and a vaccine booster dose with maternal and umbilical cord antibody levels at delivery","volume":"139","author":"Y J Yang","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref142","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cmi.2021.10.003","article-title":"Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study","volume":"28","author":"A Rottenstreich","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"03","key":"ref143","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1093\/cid\/ciac480","article-title":"Kinetics of maternally derived anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in infants in relation to the timing of antenatal vaccination","volume":"76","author":"A Rottenstreich","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref144","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1038\/s41467-022-32188-1","article-title":"Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy","volume":"13","author":"M Prahl","year":"2022","journal-title":"Nat Commun"},{"issue":"02","key":"ref145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2204399","article-title":"Maternal vaccination and risk of hospitalization for COVID-19 among Infants","volume":"387","author":"N B Halasa","year":"2022","journal-title":"N Engl J Med"},{"issue":"08","key":"ref146","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41591-022-01877-1","article-title":"Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance","volume":"28","author":"L Cao","year":"2022","journal-title":"Nat Med"},{"issue":"04","key":"ref147","doi-asserted-by":"crossref","first-page":"e0298407","DOI":"10.1371\/journal.pone.0298407","article-title":"Facilitators and barriers to vaccination uptake in pregnancy: a qualitative systematic review","volume":"19","author":"M S Razai","year":"2024","journal-title":"PLoS One"},{"issue":"39","key":"ref148","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.15585\/mmwr.mm6939a2","article-title":"Influenza and Tdap vaccination coverage among pregnant women - United States, April 2020","volume":"69","author":"H Razzaghi","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"01","key":"ref149","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1186\/s12913-021-06962-8","article-title":"An evaluation of an influenza vaccination campaign targeting pregnant women in 27 clinics in two provinces of South Africa, 2015 - 2018","volume":"21","author":"K Bishop","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"n1138","DOI":"10.1136\/bmj.n1138","article-title":"COVID-19 vaccination hesitancy","volume":"373","author":"M S Razai","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"ref151","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/vaccines9121455","article-title":"Educational interventions on pregnancy vaccinations during childbirth classes improves vaccine coverages among pregnant women in Palermo's Province","volume":"9","author":"C Costantino","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"08","key":"ref152","doi-asserted-by":"crossref","first-page":"taad138","DOI":"10.1093\/jtm\/taad138","article-title":"Interventions to increase vaccination against COVID-19, influenza and pertussis during pregnancy: a systematic review and meta-analysis","volume":"30","author":"M S Razai","year":"2023","journal-title":"J Travel Med"},{"key":"ref153","first-page":"CAT.22.0198","article-title":"Combating misinformation as a core function of public health","author":"J Knudsen","year":"2023","journal-title":"NEJM Catal"},{"issue":"01","key":"ref154","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-021-00279-w","article-title":"Overcoming vaccine hesitancy in low-income and middle-income regions","volume":"7","author":"C Simas","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"04","key":"ref155","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/vaccines11040869","article-title":"Health systems determinants of delivery and uptake of maternal vaccines in low- and middle-income countries: a qualitative systematic review","volume":"11","author":"B Davies","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"03","key":"ref156","first-page":"102","article-title":"Mobile health interventions for improving maternal and child health outcomes in South Africa: a systematic review","volume":"8","author":"E Mbunge","year":"2024","journal-title":"Glob Health J"},{"issue":"01","key":"ref157","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1186\/s12889-024-18713-5","article-title":"Interventions to increase vaccination in vulnerable groups: rapid overview of reviews","volume":"24","author":"G Norman","year":"2024","journal-title":"BMC Public Health"},{"issue":"06","key":"ref158","doi-asserted-by":"crossref","first-page":"e024449","DOI":"10.1136\/bmjopen-2018-024449","article-title":"Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality","volume":"9","author":"N Roos","year":"2019","journal-title":"BMJ Open"},{"issue":"06","key":"ref160","doi-asserted-by":"crossref","first-page":"e1059","DOI":"10.1016\/S2214-109X(24)00092-5","article-title":"Facilitating the development of urgently required combination vaccines","volume":"12","author":"W P Hausdorff","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"02","key":"ref161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"J L Liang","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"ref162","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/jpm11111196","article-title":"Comprehensive overview of vaccination during pregnancy in Europe","volume":"11","author":"A A Simionescu","year":"2021","journal-title":"J Pers Med"},{"issue":"12","key":"ref165","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/vaccines11121733","article-title":"Interventions to improve knowledge, attitudes, and uptake of recommended vaccines during pregnancy and postpartum: a scoping review","volume":"11","author":"I Ayouni","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"06","key":"ref166","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40121-024-00975-6","article-title":"Cost-effectiveness analysis of maternal immunization with RSVpreF vaccine for the prevention of respiratory syncytial virus among infants in Spain","volume":"13","author":"J \u00c1lvarez Aldean","year":"2024","journal-title":"Infect Dis Ther"},{"issue":"07","key":"ref167","doi-asserted-by":"crossref","first-page":"e0003418","DOI":"10.1371\/journal.pgph.0003418","article-title":"Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries","volume":"4","author":"S Malhotra","year":"2024","journal-title":"PLOS Glob Public Health"},{"issue":"02","key":"ref168","doi-asserted-by":"crossref","first-page":"e0002834","DOI":"10.1371\/journal.pgph.0002834","article-title":"The role of global health partnerships in vaccine equity: a scoping review","volume":"4","author":"C Nunes","year":"2024","journal-title":"PLOS Glob Public Health"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2471-6906.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T22:49:46Z","timestamp":1749250186000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2471-6906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":157,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2025,6,6]]},"published-print":{"date-parts":[[2025,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2471-6906","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]}}}